Literature DB >> 5234187

[Chromosomal studies in chronic myeloic leukemia].

U Wolf, H Merker, W Böckelmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5234187     DOI： 10.1007/bf01747172

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN： 0023-2173


× No keyword cloud information.
  29 in total

1.  COMPARISON OF PHILADELPHIA CHROMOSOME-POSITIVE AND-NEGATIVE PATIENTS WITH CHRONIC MYELOCYTIC LEUKEMIA.

Authors:  S KRAUSS; J E SOKAL; A A SANDBERG
Journal:  Ann Intern Med       Date:  1964-10       Impact factor: 25.391

2.  THE DISTRIBUTION OF THE PHILADELPHIA CHROMOSOME IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA.

Authors:  J WHANG; E FREI; J H TJIO; P P CARBONE; G BRECHER
Journal:  Blood       Date:  1963-12       Impact factor: 22.113

3.  THE EFFECT OF TREATMENT IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA. HEMATOLOGIC AND CYTOGENETIC STUDIES.

Authors:  P P CARBONE; J H TJIO; J WHANG; J B BLOCK; W B KREMER; E FREI
Journal:  Ann Intern Med       Date:  1963-11       Impact factor: 25.391

4.  CHROMOSOME STUDIES DURING EARLY AND TERMINAL CHRONIC MYELOID LEUKAEMIA.

Authors:  N H KEMP; J L STAFFORD; R TANNER
Journal:  Br Med J       Date:  1964-04-18

5.  Chronic granulocytic leukemia and the Philadelphia chromosome.

Authors:  P H FITZGERALD; A ADAMS; F W GUNZ
Journal:  Blood       Date:  1963-02       Impact factor: 22.113

6.  Chromosomal alteration of erythropoietic cells in chronic myeloid leukemia.

Authors:  J M TRUJILLO; S OHNO
Journal:  Acta Haematol       Date:  1963-05       Impact factor: 2.195

7.  Cytogenetic studies in chronic myeloid leukaemia and acute leukaemia associated with monogolism.

Authors:  I M TOUGH; W M COURT BROWN; A G BAIKIE; K E BUCKTON; D G HARNDEN; P A JACOBS; M J KING; J A McBRIDE
Journal:  Lancet       Date:  1961-02-25       Impact factor: 79.321

8.  Study of chromosomes in human leukaemia by a direct method.

Authors:  M A KINLOUGH; H N ROBSON
Journal:  Br Med J       Date:  1961-10-21

9.  Comparison of chromosome constitution in chronic myelocytic leukemia and other myeloproliferative disorders.

Authors:  A A SANDBERG; T ISHIHARA; L H CROSSWHITE; T S HAUSCHKA
Journal:  Blood       Date:  1962-10       Impact factor: 22.113

10.  The kinetics of cell proliferation in cultures of human peripheral blood.

Authors:  A A MACKINNEY; F STOHLMAN; G BRECHER
Journal:  Blood       Date:  1962-03       Impact factor: 22.113
View more
  8 in total

1.  [On the activity of folate-dependent enzymes in leukocytes in mongolism].

Authors:  H Holzmann; B Morsches; W Sachsse
Journal:  Klin Wochenschr       Date:  1967-04-01

Review 2.  [Philadelphia chromosome].

Authors:  D K Hossfeld; A A Sandberg
Journal:  Klin Wochenschr       Date:  1970-12-15

Review 3.  [On the problem of assigning genes to definite human autosomes with the aid of chromosome aberrations].

Authors:  K Bender; H Ritter; U Wolf
Journal:  Humangenetik       Date:  1967

4.  [Commention on the paper: "Philadelphia chromosome" by Hossfeld, D.K. and Sandberg, A.A., Klin.Wschr. 48, 1431, 1970].

Authors:  J Bauke
Journal:  Klin Wochenschr       Date:  1971-10-15

5.  [Double Philadelphia chromosome and isochromosome 17 in the terminal phase of chronic myeloid leukemia].

Authors:  W Stich; F Back; P Dörmer; A Tsirimbas
Journal:  Klin Wochenschr       Date:  1966-03-15

6.  [Chromosome translocation in chronic myeloproliferative syndrome. Report on 2 observations with special reference to pathogenetic viewpoints].

Authors:  H Merker; G Schneider; P Burmeister; U Wolf
Journal:  Klin Wochenschr       Date:  1968-06-01

7.  [Philadelphia chromosome and leukocyte alkaline phosphatase in chronic myeloses].

Authors:  A Gropp; R Fischer; G Niederalt; M P Klesse; S Hensen
Journal:  Klin Wochenschr       Date:  1968-02-15

8.  [Myelomonocytic leukemia with Philadelphia-positive and Philadelphia-negative cell lines in early childhood (author's transl)].

Authors:  H Wehinger; H Niederhoff; D Bethge; W Künzer; H Hoehn; G Cohen
Journal:  Klin Wochenschr       Date:  1975-05-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.